RimaARachidMD

PubMed

• 265 citations
  AR101 Oral Immunotherapy for Peanut Allergy
  Brian P. Vickery, Andrea Vereda, Thomas B. Casale, Kirsten Beyer, George Du Toit
  The New England Journal of Medicine. 2018-11-22
• 131 citations
  Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial.
  J. Andrew Bird, Jonathan M. Spergel, Stacie M. Jones, Rima Rachid, Amal Assa'ad
  The Journal of Allergy and Clinical Immunology. in Practice. 2017-10-31
• 51 citations
  Oral immunotherapy with omalizumab reverses the Th2 cell‐like programme of regulatory T cells and restores their function
  Azza Abdel-Gadir, Lynda C. Schneider, Alessandro Casini, Louis-Marie Charbonnier, Sara V. Little
  Clinical and Experimental Allergy. 2018-07-01

Journal Articles

• Original Article Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab  
  Dale T Umetsu, Rima Rachid, Jennifer LeBovidge, Lynda Schneider, ScienceDirect
• Long-term outcome of peanut OIT facilitated initially by omalizumab  
  Yee R, AlbuhairiS, Noh E, El Khoury K, Rezaei S, Abdel-Gadir A, Umetsu D, Burkes-Roberts E, Lebovidge J, Schneider L, Rachid R, J Allergy Clin Immunol Pract, 1/1/2018
• Theme Editorial: Food Allergy: What is on the menu?  
  Rachid R and Keet CA, J Allergy Clin Immunol Pract, 1/1/2018
• Current Status and Unanswered Questions for Food Allergy Treatments  
  Rachid R and Keet CA, J Allergy Clin Immunol Pract, 1/1/2018
• AR101 Oral Immunotherapy for peanut allergy  
  The PALISADE Group of Clinical Investigators, Vickery BP, Vereda A, Casale TB, Beyer K, du Toit G, Hourihane JO, Jones SM, Shreffler WG, Marcantonio A, Zawadzki R, She..., New Eng J Med, 1/1/2018
• Efficacy and Safety of Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-controlled Phase 2 Clinical Trial  
  Bird JA, Spergel JM, Jones SM,�Rachid R, Assa'ad AH, Wang J, Leonard SA, Laubach SS, Kim EH, Vickery BP, Davis BP, Heimall J, Cianferoni A, MacGinnitie AJ, Crestani E,..., J Allergy Clin Immunol Pract, 1/1/2018
• Construction and Validation of a Disease-specific Quality of Life (HR-QOL) Instrument for Patients with Primary Antibody Deficiency Disease  
  Ballow M, Conaway M, Sriaroon P, Rachid R, Seeborg F, Duff C, Bonilla F, Younger E, Ralph Shapiro R, J Allergy Clin Immunol, 1/1/2017
• The role of the gut microbiota in food allergy  
  Rachid R and Chatila TA, Curr Opin Pediatr, 1/28/2016
• Omalizumab facilitates rapid oral desensitization for peanut allergy  
  MacGinnitie AJ, Rachid R, Gragg H, Little SV, Lakin P, Cianferoni A, Heimall J, Makhija M, Robison R, Chinthrajah RS, Lee J, Lebovidge J, Dominguez T, Rooney C, Lewis ..., J Allergy Clin Immunol, 1/5/2016
• The heterogeneity of oral immunotherapy trials: Implications and Future directions  
  Yee C, Rachid R, Cur Aller Asthma Reports, 1/1/2016
• Acquisition by Regulatory T cellsof a Th2-Like Cell Program Impairs Oral Tolerance and Promotes Food Allergy  
  Novas Rivas M, Burton OT, Charbonnier, LM, Georgiev, P, Oettgen HC, Rachid R, Chatila TA, Immunity, 1/17/2015
• TNFRSF13B hemizygosity reveals TACI haploinsufficiency at later stages of B-cell development  
  Romberg N, Virdee M, Chamberlain N, Oe T, Schickel JN, Perkins T, Cantaert T, Rachid R, Rosengren S, Palazzo R, Geha R, Cunningham-Rundles C, Meffre E, J Allergy Clin Immunol, 1/1/2015
• Oral Immunotherapy and Anti-IgE Antibody Treatment for Food Allergy  
  Umetsu DT, Rachid R, Schneider LC, World Allergy Organ J, 1/1/2015
• The psychological impact of oral immunotherapy for children with food allergy: Perceived benefits and treatment burden  
  LeBovidge J, Haskell S, Olney E, Hoyte L, Rachid R, Nadeau K, Umetsu D, Schneider LC, Clinical Practice in Pediatric Psychology, 1/1/2014
•  
  Burton OT, Logsdon SL, Zhou JS, Medina-Tamayo J, Abdel-Gadir A, Noval Rivas M, Koleoglou KJ, Chatila TA, Schneider LC, Rachid R, Umetsu DT, Oettgen HC, J Allergy Clin Immunol, 1/1/2014
• A pilot study of�omalizumab to facilitate rapid oral desensitization in high-risk peanut allergic patients  
  Schneider L,��Rachid R,���LeBovidge, J, Blood E, Muttal, M and�Umetsu D, J Allergy Clin Immunol, 1/1/2013
• Ask the Expert: Administration of Intravenous Immunoglobulin to a Patient with Hypogammaglobulinemia and Anti-IgA Antibodies  
  Lieberman, P and Rachid R, JACI in Practice, 1/1/2013
• VID-associated TACI mutations affect autoreactive B cell selection and activation  
  Romberg N, Chamberlain N, Saadoun D, Gentile M, Kinnunen T, Ng YS, Virdee M, Menard L, Cantaert T, Morbach H,�Rachid R, Martinez-Pomar N, Matamoros N, Geha R, Grimbach..., J Clin Invest, 1/1/2013
• Reply to Kiani-Alikhan S  
  Rachid R and Bonilla FA, J Allergy Clin Immunol, 1/2/2012
• The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: A comprehensive review of the literature  
  Rachid R, Bonilla FA, J Allergy Clin Immunol, 1/1/2012
• Reply to Szczeklik A  
  Rachid R, Leslie D, Schneider L and Twarog F, J Allergy Clin Immunol, 1/21/2011
• Association of anti-IgA antibodies with adverse reactions to gamma-globulin infusion  
  Rachid R, Castells M, Cunningham-Rundles C, Bonilla FA, J Allergy Clin Immunol, 1/1/2011
• Hypersensitivity to corticosteroids: an infrequent but potentially life threatening condition  
  Rachid R, Leslie D, Schneider L, Twarog F, J Allergy Clin Immunol, 1/1/2011
• Reply to Calogiuri  
  Rachid R, Leslie D, Schneider L, Twarog F, J Allergy Clin Immunol, 1/1/2011
• TACI mutation in CVID and IgA deficiency (review)  
  Rachid R, Castigli E, Geha R, Bonilla F, Curr Allergy Asthma Rep, 1/1/2006
• Join now to see all

Books/Book Chapters

• Immunodeficiency Foundation Handbook 
  Chapter: Selective IgA deficiency Chapter 
  Rachid R and Bonilla FA2012
• Up-to-date 
  Chapter: Hypersensitivity to corticosteroids 
  Rachid REditors: Feldweg.Up-to-date, Waltham, MA2012
• Case studies in Immunology 
  Chapter: Autoimmune lymphoproliferative syndrome (ALPS) 
  Page 173 - 178Rachid R, Geha RSEditors: Rosen, Geha.Garland PublishingEdition 3rd,2001

Abstracts/Posters

• Systemic Reactions in Pediatric Patients Receiving Standardized Allergen Subcutaneous Immunotherapy with and without Seasonal Dose�Adjustment
  Albuhairi S, Sare T, Lakin P, El Khoury K, Crestani E, Schneider LC, Anzaldi R, Patterson A, Rachid R, American Academy of Allergy, Asthma and Clinical Immunology, Orlando, FL, 1/1/2018
• Peanut Using AR101 Peanut Oral Immunotherapy in a Roll-Over Safety Study ARC002
  J. Andrew Bird, Michael J. Welch, Jonathan M. Spergel, Stacie M. Jones, Rima Rachid, Amal H. Assa'ad, Julie Wang, Stephanie A. Leonard, Susan Stefanac Laubach, Edwin ..., American�College�of Allergy, Asthma & Immunology Annual Scientific Meeting, Seattle, WA, 1/1/2018
• Allergy in Infancy Is Associated with Dysbiosis of the Intestinal Microbiota
  Rima Rachid, Georg Gerber, Ning Li, Dale T. Umetsu, Lynn Bry, Talal A. Chatila, American Academy of Allergy Asthma and Clinical Immunology, San Diego, CA, 1/1/2016
• The Efficacy of AR101, a Peanut-Derived Pharmaceutical for Oral Immunotherapy (OIT), Is Maintained and Tolerability Is Increased with Low-Dose Maintenance Therapy
  J. Andrew Bird, Jonathan M. Spergel, Stacie M. Jones, Rima Rachid, Amal H. Assa'ad, Julie Wang, Stephanie A. Leonard, Susan Stefanac Laubach, Edwin H. Kim, Benjamin P..., American Academy of Allergy Asthma and Clinical Immunology, San Diego, CA, 1/1/2016
• Join now to see all

Lectures

• The Role of Gut Microbiota in Food Allergy 
  1/1/2018
• Role of Microbiota in Food Allergy and Tolerance 
  1/1/2018
• Systemic reactions to Subcutaneous Allergy Immunotherapy with and without seasonal dose adjustment 
  1/1/2018
• The Role of the Gut Microbiota in Food Allergy 
  Cambridge, MA - 1/1/2017
• Food Challenge in practice: safe and simplified 
  San Francisco, CA, 2016; Boston, MA, 2017 - 1/1/2017
• Common Variable Immunodeficiency and Autoimmunity 
  Boston, MA - 1/1/2017
• Update on Food Allergy Research 
  Danvers, MA - 1/1/2016
• The safety and tolerability of AR101 
  Vienna, Austria - 1/1/2016
• Non-infectious complications of Common Variable Immunodeficiency 
  San Diego, CA, 2014; Houston, TX, 2015 - 1/1/2015
• Allergy &Immunology MCQs 
  Abu Dhabi, United Arab Emirates - 1/1/2015
• Update on Peanut Immunotherapy 
  1/1/2015
• Immunology Board Review 
  Abu Dhabi, United Arab Emirates - 1/1/2015
• Allergy Board Review 
  Abu Dhabi, United Arab Emirates - 1/1/2015
• The Nuts & Bolts of Immunoglobulin Therapy 
  Norwood, MA - 1/1/2014
• Immunoglobulin Therapy, Safety Considerations, Adverse Reactions 
  San Diego, CA - 1/1/2014
• Adverse reactions to Immunoglobulin infusions 
  1/1/2013
• Update on Clinical and Translational Research in Food allergy 
  Salem, MA - 1/1/2013
• Approach to patients with Primary Immunodeficiency 
  St. Elizabeth Hospital, Brighton, MA - 1/1/2012
• Primary Immunodeficiencies, Diagnosis and Work up 
  Harvard Medical School, Boston, MA - 1/1/2010
• Primary Immunodeficiencies: A review for the General Pediatrician 
  1/1/2009
• Update on Common Variable Immunodeficiency: From patients to bench and from bench to patients 
  1/1/2008
• Update on Allergen Immunotherapy Standardization 
  1/1/2008
• Immunotherapy Standardization 
  1/1/2006
• The consequences of T cell activation on WASP-WIP interaction 
  1/1/2002
• Parathione poisoning in children: 15 years� experience in a tertiary care center, a clinical retrospective study 
  Nice, France - 1/1/1997
• Join now to see all

Other

• Interview in Vector Boston Children�s Hospital Science and Innovation blog, on the upcoming cutting edge Phase I Fecal Microbiota Trial in Peanut Allergic Patients 
  
  1/1/2018
• Interview on the phase I Fecal Microbiota Trial in Peanut Allergic Patients 
  NBC Boston TV channel
  1/1/2018
• Interview in Vector Boston Children�s Hospital Science and Innovation blog, on the very promising results that emerged from the multi-site omalizumab/peanut oral immun... 
  Journal of Allergy and Clinical Immunology
  1/1/2016
• Interview in on symptoms and treatment of allergic rhino-conjunctivitis 
  
  Livescience.com
  1/1/2014
• Interview with Donald Leung, MD, PhD , Editor-in-Chief, Journal of Allergy and Clinical Immunology (JACI) discussing the very promising results that emerged from phase... 
  JACI website
  1/1/2013
• Interview with Tripp Underwood, senior writer for Boston Children�s Hospital Marketing and Communication development, on the very promising results that emerged from p... 
  Journal of Allergy and Clinical Immunology
  1/1/2013
• TV interview on food allergies 
  Future TV, Major Regional Middle Eastern TV Channel
  1/1/2009
• Interview on Immunodeficiencies 
  Al-Nahar newspaper, Major Regional Middle Eastern Newspaper
  1/1/2009
• Join now to see all